Entry |
|
Name |
Bictegravir sodium (JAN/USAN) |
Formula |
C21H17F3N3O5. Na
|
Exact mass |
471.1018
|
Mol weight |
471.36
|
Structure |

|
Simcomp |
|
Class |
|
Remark |
Product (mixture): | D11039<JP/US> |
|
Efficacy |
Antiviral, HIV integrase inhibitor |
Comment |
Treatment of HIV-1 infection
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG03135 HIV integrase inhibitor
DG02404 Bictegravir
D10910 Bictegravir sodium
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV integrase inhibitor
D10910 Bictegravir sodium (JAN/USAN)
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
DG03135 HIV integrase inhibitor
DG02404 Bictegravir
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C8y C 16.3094 -16.8498
2 N4y N 16.3094 -15.4730
3 C8x C 17.4798 -14.7844
4 C8y C 18.7190 -15.4730
5 C8y C 18.7190 -16.8498
6 C8y C 17.4798 -17.5383
7 C5x C 15.1390 -17.5383
8 N1y N 13.8998 -16.8498
9 C1y C 13.8998 -15.4730
10 C1x C 15.1390 -14.7844
11 C1y C 12.7294 -17.5383
12 C1x C 11.5591 -16.8498
13 C1y C 11.5591 -15.4730
14 O2x O 12.7294 -14.7844
15 O5x O 15.1390 -18.9152
16 O1a O 17.4798 -18.9152 #-
17 O5x O 19.8894 -17.5383
18 C5a C 19.8894 -14.7844
19 N1b N 21.0597 -15.4730
20 O5a O 19.8894 -13.4076
21 C1b C 22.2301 -14.7844
22 C8y C 23.4004 -15.4730
23 C8y C 24.5709 -14.7844
24 C8x C 25.8101 -15.4730
25 C8y C 25.8101 -16.8498
26 C8x C 24.6397 -17.5383
27 C8y C 23.4004 -16.8498
28 X F 22.2301 -17.5383
29 X F 26.9804 -17.5383
30 C1x C 10.3696 -16.1597
31 C1x C 11.5400 -18.2250
32 X F 24.5709 -13.4109
33 Z Na 18.9700 -19.8100 #+
BOND 36
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 1 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 2 10 1
12 8 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 9 14 1
17 7 15 2
18 6 16 1
19 5 17 2
20 4 18 1
21 18 19 1
22 18 20 2
23 19 21 1
24 21 22 1
25 22 23 2
26 23 24 1
27 24 25 2
28 25 26 1
29 26 27 2
30 22 27 1
31 27 28 1
32 25 29 1
33 13 30 1 #Up
34 11 31 1 #Up
35 30 31 1
36 23 32 1
|